🚀 VC round data is live in beta, check it out!
- Public Comps
- Select Medical
Select Medical Valuation Multiples
Discover revenue and EBITDA valuation multiples for Select Medical and similar public comparables like MLP Sağlık, Akdital, Siloam Hospitals, Huaxia Eye Hospital Group and more.
Select Medical Overview
About Select Medical
Select Medical Holdings Corp is a healthcare company that operates through three segments: critical illness recovery hospitals, rehabilitation hospitals, and outpatient rehabilitation clinics. Critical illness recovery hospitals which derives maximum revenue consists of hospitals designed to serve the needs of patients recovering from critical illnesses, often with complex medical needs. The rehabilitation hospital segment consists of hospitals designed to serve patients that require intensive physical rehabilitation care. Patients are typically admitted to critical illness recovery hospitals and rehabilitation hospitals from general acute care hospitals. The outpatient rehabilitation segment consists of clinics that provide physical, occupational, and speech rehabilitation services.
Founded
2004
HQ

Employees
44.1K
Website
Sectors
Financials (LTM)
EV
$5B
Select Medical Financials
Select Medical reported last 12-month revenue of $6B and EBITDA of $504M.
In the same LTM period, Select Medical generated $635M in gross profit, $504M in EBITDA, and $148M in net income.
Revenue (LTM)
Select Medical P&L
In the most recent fiscal year, Select Medical reported revenue of $5B and EBITDA of $531M.
Select Medical expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $6B | XXX | $5B | XXX | XXX | XXX |
| Gross Profit | $635M | XXX | $629M | XXX | XXX | XXX |
| Gross Margin | 11% | XXX | 12% | XXX | XXX | XXX |
| EBITDA | $504M | XXX | $531M | XXX | XXX | XXX |
| EBITDA Margin | 9% | XXX | 10% | XXX | XXX | XXX |
| EBIT Margin | 6% | XXX | 6% | XXX | XXX | XXX |
| Net Profit | $148M | XXX | $146M | XXX | XXX | XXX |
| Net Margin | 3% | XXX | 3% | XXX | XXX | XXX |
| Net Debt | — | — | $2B | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Select Medical Stock Performance
Select Medical has current market cap of $2B, and enterprise value of $5B.
Market Cap Evolution
Select Medical's stock price is $16.39.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $5B | $2B | 0.0% | XXX | XXX | XXX | $1.18 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialSelect Medical Valuation Multiples
Select Medical trades at 0.9x EV/Revenue multiple, and 9.7x EV/EBITDA.
EV / Revenue (LTM)
Select Medical Financial Valuation Multiples
As of April 18, 2026, Select Medical has market cap of $2B and EV of $5B.
Equity research analysts estimate Select Medical's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Select Medical has a P/E ratio of 13.7x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $2B | XXX | $2B | XXX | XXX | XXX |
| EV (current) | $5B | XXX | $5B | XXX | XXX | XXX |
| EV/Revenue | 0.9x | XXX | 0.9x | XXX | XXX | XXX |
| EV/EBITDA | 9.7x | XXX | 9.2x | XXX | XXX | XXX |
| EV/EBIT | 14.0x | XXX | 14.5x | XXX | XXX | XXX |
| EV/Gross Profit | 7.7x | XXX | 7.7x | XXX | XXX | XXX |
| P/E | 13.7x | XXX | 13.9x | XXX | XXX | XXX |
| EV/FCF | — | XXX | 41.6x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Select Medical Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Select Medical Margins & Growth Rates
Select Medical's revenue in the last 12 month grew by 5%.
Select Medical's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.0M for the same period.
Select Medical's rule of 40 is 14% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Select Medical's rule of X is 20% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Select Medical Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 5% | XXX | 4% | XXX | XXX | XXX |
| EBITDA Margin | 9% | XXX | 10% | XXX | XXX | XXX |
| EBITDA Growth | 7% | XXX | (0%) | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 14% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 20% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.0M | XXX | XXX | XXX |
| G&A Expenses to Revenue | 3% | XXX | 3% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 5% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Select Medical Public Comps
See public comps and valuation multiples for other Hospitals & Clinics comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Select Medical | XXX | XXX | XXX | XXX | XXX | XXX |
| MLP Sağlık | XXX | XXX | XXX | XXX | XXX | XXX |
| Akdital | XXX | XXX | XXX | XXX | XXX | XXX |
| Siloam Hospitals | XXX | XXX | XXX | XXX | XXX | XXX |
| Huaxia Eye Hospital Group | XXX | XXX | XXX | XXX | XXX | XXX |
| Dr. Soliman Abdul Kader | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Select Medical M&A Activity
Select Medical acquired XXX companies to date.
Last acquisition by Select Medical was on XXXXXXXX, XXXXX. Select Medical acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Select Medical
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialSelect Medical Investment Activity
Select Medical invested in XXX companies to date.
Select Medical made its latest investment on XXXXXXXX, XXXXX. Select Medical invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Select Medical
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Select Medical
| When was Select Medical founded? | Select Medical was founded in 2004. |
| Where is Select Medical headquartered? | Select Medical is headquartered in United States. |
| How many employees does Select Medical have? | As of today, Select Medical has over 44K employees. |
| Who is the CEO of Select Medical? | Select Medical's CEO is Thomas P. Mullin. |
| Is Select Medical publicly listed? | Yes, Select Medical is a public company listed on NYSE. |
| What is the stock symbol of Select Medical? | Select Medical trades under SEM ticker. |
| When did Select Medical go public? | Select Medical went public in 2009. |
| Who are competitors of Select Medical? | Select Medical main competitors are MLP Sağlık, Akdital, Siloam Hospitals, Huaxia Eye Hospital Group. |
| What is the current market cap of Select Medical? | Select Medical's current market cap is $2B. |
| What is the current revenue of Select Medical? | Select Medical's last 12 months revenue is $6B. |
| What is the current revenue growth of Select Medical? | Select Medical revenue growth (NTM/LTM) is 5%. |
| What is the current EV/Revenue multiple of Select Medical? | Current revenue multiple of Select Medical is 0.9x. |
| Is Select Medical profitable? | Yes, Select Medical is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Select Medical? | Select Medical's last 12 months EBITDA is $504M. |
| What is Select Medical's EBITDA margin? | Select Medical's last 12 months EBITDA margin is 9%. |
| What is the current EV/EBITDA multiple of Select Medical? | Current EBITDA multiple of Select Medical is 9.7x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.